Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | QPCT | Q16769 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20953982 | 1.00 | FDPS (0.47) | FDPSTBXAS1CYP11B1CYP11B2CYP19A1 | |
| Iodide SCHEMBL4367921 | 0.98 | FDPS (0.46) | FDPSTBXAS1CYP11B1CYP11B2CYP19A1 | |
| Sulfuric Acid SCHEMBL20853723 | 0.89 | FDPS (0.47) | FDPSTBXAS1CYP19A1QPCTALDH1A1 | |
| SCHEMBL17484070 | 0.84 | TBXAS1 (0.47) | FDPSTBXAS1CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL143560 | 0.82 | FDPS (0.46) | FDPSTBXAS1CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL4681300 | 0.82 | FDPS (0.50) | FDPSTBXAS1ALDH1A1 | |
| SCHEMBL4681306 | 0.82 | FDPS (0.50) | FDPSTBXAS1CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL18638657 | 0.82 | FDPS (0.46) | FDPSTBXAS1CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL21796369 | 0.81 | TBXAS1 (0.53) | FDPSTBXAS1CYP19A1QPCT | |
| SCHEMBL18216561 | 0.81 | FDPS (0.48) | FDPSTBXAS1CYP11B1CYP11B2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107001976-A | The method for improving the anti-coking of lubricating composition | NYCO公司 | 2017-08-01 | — | — | CN | claimed |
| CN-101887802-B | Quasi-solid electrolyte used for dye-sensitized solar cell and preparation method thereof | TIANJIN LISHEN BATTERY | 2012-06-06 | — | — | CN | claimed |
| CN-101887802-A | Quasi-solid electrolyte used for dye-sensitized solar cell and preparation method thereof | TIANJIN LISHEN BATTERY | 2010-11-17 | — | — | CN | claimed |
| EP-2343298-B9 | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors | INCYTE HOLDINGS CORP (US) | 2020-05-06 | — | — | EP | disclosed |
| CN-104471108-B | Copper coating forming agent and method for forming copper coating | 四国化成工业株式会社 | 2020-05-05 | — | — | CN | disclosed |
| US-10405422-B2 | Copper film-forming agent and method for forming copper film | SHIKOKU CHEMICALS CORPORATION (JP) | 2019-09-03 | — | — | US | disclosed |
| CN-108690217-A | Carbon fiber recycles composition and method | 波音公司 | 2018-10-23 | — | — | CN | disclosed |
| US-20180214561-A1 | EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2018-08-02 | — | — | US | disclosed |
| CN-107406607-A | Fiber reinforced composite material two-component-type composition epoxy resin and fiber reinforced composite material | 东丽株式会社 | 2017-11-28 | — | — | CN | disclosed |
| CN-104818513-B | Electroplating pool and metal coating and forming method thereof | 丰田自动车株式会社 | 2017-08-18 | — | — | CN | disclosed |
| US-20170219927-A1 | COMPOSITION FOR RESIST PATTERNING AND METHOD FOR FORMING PATTERN USING SAME | AZ ELECTRIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) | 2017-08-03 | — | — | US | disclosed |
| US-20140357503-A1 | METHOD AND ARRAY FOR IDENTIFYING HISTONE-CODE-RELATED ANALYTES | UVIC INDUSTRY PARTNERSHIPS INC. (CA) | 2014-12-04 | — | — | US | disclosed |
| CN-102015960-B | Composition comprising photochromic dyes in ionic solvents | ESSILOR INT | 2014-11-19 | — | — | CN | disclosed |
| US-20130164694-A1 | RINSE SOLUTION FOR LITHOGRAPHY AND PATTERN FORMATION METHOD EMPLOYING THE SAME | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2013-06-27 | — | — | US | disclosed |
| CN-101887802-B | Quasi-solid electrolyte used for dye-sensitized solar cell and preparation method thereof | TIANJIN LISHEN BATTERY | 2012-06-06 | — | — | CN | disclosed |
| CN-102015960-A | Composition comprising photochromic dyes in ionic solvents | ESSILOR INT | 2011-04-13 | — | — | CN | disclosed |
| CN-101887802-A | Quasi-solid electrolyte used for dye-sensitized solar cell and preparation method thereof | TIANJIN LISHEN BATTERY | 2010-11-17 | — | — | CN | disclosed |
| US-20100022559-A1 | BISOXIMES AS FUNGICIDES | BAYER CROPSCIENCE AG (DE) | 2010-01-28 | — | — | US | disclosed |
| EP-1951842-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | BASF SE (DE) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007054470-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | BASF SE (DE) | 2007-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10405422-B2 | Copper film-forming agent and method for forming copper film | AOC1, AOC2, SOD1 | FDPS 370/4885TBXAS1 2491/4885CYP11B1 4017/4885 |
| US-20180214561-A1 | EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF | MRPL38, CXCL8, ALG8 | FDPS 366/4885TBXAS1 508/4885CYP11B1 343/4885 |
| US-20100022559-A1 | BISOXIMES AS FUNGICIDES | DDT, FHIT, CYP4X1 | FDPS 458/4885TBXAS1 2974/4885CYP11B1 302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.